Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insufficient Physical Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02173457
What this trial is testing

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 740
Testing effectiveness (Phase 2)Study completedNCT06057064
What this trial is testing

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 116
Large-scale testing (Phase 3)Study completedNCT01703221
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 414
Large-scale testing (Phase 3)Study completedNCT06010004
What this trial is testing

A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 401
Large-scale testing (Phase 3)Study completedNCT00095147
What this trial is testing

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 431
Large-scale testing (Phase 3)Study completedNCT01697592
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 585
Not applicableNot Yet RecruitingNCT06784544
What this trial is testing

The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity

Who this might be right for
Sleep, InadequateEnergy DeficitIron Absorption+1 more
United States Army Research Institute of Environmental Medicine 24
Not applicableStudy completedNCT02682771
What this trial is testing

Positive Airway Pressure Versus Breathing Exercises With Load Inspiratory in Patients Undergoing Bariatric Surgery

Who this might be right for
Inadequate or Impaired Respiratory Function
Universidade Metodista de Piracicaba 60
Not applicableStudy completedNCT01388309
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 64
Large-scale testing (Phase 3)Study completedNCT02226003
What this trial is testing

Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 291
Large-scale testing (Phase 3)Study completedNCT01294423
What this trial is testing

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 DiabetesHigh Blood Sugar
AstraZeneca 261
Large-scale testing (Phase 3)Study completedNCT06354660
What this trial is testing

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Who this might be right for
Diabetes Type 2
Eli Lilly and Company 537
Large-scale testing (Phase 3)Study completedNCT00121641
What this trial is testing

Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 1,035
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Not applicableStudy completedNCT05394792
What this trial is testing

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 111
Large-scale testing (Phase 3)Study completedNCT00327015
What this trial is testing

BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes
AstraZeneca 1,306
Testing effectiveness (Phase 2)Study completedNCT00263276
What this trial is testing

A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
AstraZeneca 389
Large-scale testing (Phase 3)Study completedNCT00810277
What this trial is testing

Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 14
Large-scale testing (Phase 3)Study completedNCT01091675
What this trial is testing

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Who this might be right for
Ankylosing Spondylitis
Spanish Foundation of Rheumatology 58
Large-scale testing (Phase 3)Study completedNCT02577016
What this trial is testing

Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 141
Next Page